Systemic treatment for prostate cancer.
Dowling
A J
AJ
Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.
Tannock
I F
IF
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D016032:Randomized Controlled Trials as Topic
D018931:Antineoplastic Agents, Hormonal